In Neuroblastoma Xenografts, Induction of EPAS1/HIF2αA Impedes Tumor Growth and Triggers Expression of Genes Highly Expressed in Noradrenergic Chromaffin Cells. This evidence concerns the gene EPAS1 and neuroblastoma.